Genentech Competitors and Similar CompaniesClear all
Opthea's competitors and similar companies include Biogen.
 Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1978 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South Yarra, AU HQ Toorak, AU | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 33 | Employees 7,605 |
Valuation ($) | Valuation ($) 711.2 m | Valuation ($) 26.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $25k (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit $146k (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($162.8m) (FY, 2025) | Net income $1.3b (FY, 2025) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products 2 (FY, 2020) | Phase II Trials Products 6 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company